Imerys Q3 2026 adjusted EBITDA rises 15% to €160 million
- Imerys’ third-quarter 2026 adjusted EBITDA rose 15% year-over-year to €160 million, supported by tight cost control and firm pricing.
- First-nine-month 2026 adjusted EBITDA climbed 7% year-over-year to €450 million.
- Project Horizon’s cost and performance improvements progressed ahead of schedule, while recent acquisitions were already earnings-accretive.
- Full-year 2026 adjusted EBITDA guidance increased to €570 million–€590 million from €550 million–€580 million.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Imerys SA published the original content used to generate this news brief on October 29, 2026, and is solely responsible for the information contained therein.